
General Care and Management of Hemophilia
This eLearning module presents Section 1 of the WFH Guidelines for the Management of Hemophilia: General Care and Management of
Year: 2021
Language: English
Author(s): World Federation of Hemophilia
Format: Video
Listen to this 90-minute webinar presented on July 30, 2021, on the WFH Guidelines for the Management of Hemophilia, 3rd edition and their practical application in the Middle East.
The session was moderated by Alok Srivastava (Professor in the Department of Haematology, and Head of the Centre for Stem Cell Research at the Christian Medical College, Vellore and Content Lead, WFH Guidelines for the Management of Hemophilia).
Speakers, including Emna Gouider (Department Head, Aziza Othmana Hospital), Abdulhakim Al-Rawas (Senior Consultant in the Pediatric Hematology/Oncology Unit, Child Health Department in Sultan Qaboos University Hospital), Magdy El Ekiaby (Head of BTC & HTC, Chabrawishi Hospital), and Cesar Haddad (Lebanese Association for Hemophilia), presented examples of regional cases followed by expert discussions and a Q&A period.
The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.
The WFH does not promote any particular pharmaceutical product and any mention of any commercial brand in this presentation is strictly for educational purposes.

This eLearning module presents Section 1 of the WFH Guidelines for the Management of Hemophilia: General Care and Management of

This eLearning module presents Section 5 of the WFH Guidelines for the Management of Hemophilia: Treatment of Specific Hemorrhages. Detailed

This eLearning module presents Section 3 of the WFH Guidelines for the Management of Hemophilia: Laboratory Diagnosis. Detailed illustrations, interactive

The World Federation of Hemophilia International Medical Card provides critical information to others in the case of an emergency.

A discussion of the mild forms of hemophilia A and hemophilia B, from epidemiology and molecular basis, via diagnosis, to

Acquired hemophilia is a rare condition caused by the production of autoantibodies, which inactivate factor VIII. This paper provides an